Unclear Diagnoses in Patients with Metastatic Disease

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia addresses the problem of unclear diagnoses affecting approximately 15% of newly diagnosed patients with metastatic disease each year and the importance of an accurate diagnosis of tumor type in selecting the proper site-specific therapies.
October 16, 2015

Targeting Multiple Pathways with Immunotherapies

Dr. Sanjiv Agarwala brings up the potential issue of toxicity that may arise in combining immunotherapies and argues that the benefits outweigh the risks.

September 20, 2013

Absorbing the Cost of Personalized Medicine

Matthew Palmgren discusses the benefits of personalized medicines